ClinCalc Pro
Menu
Triptan (5-HT₁B/1D agonist)

Eletriptan

Brand names: Relpax

Adult dose

Dose: 40mg at onset; may repeat after 2h if recurrence; max 80mg/24h
Route: Oral
Frequency: PRN; max 2 doses per attack

Clinical pearls

  • NICE NG150: triptan first-line for acute migraine; eletriptan strongest receptor binding among oral triptans
  • BASH / ABN migraine guidance
  • Limit use ≤10 days/month to avoid medication overuse headache

Contraindications

  • IHD
  • Uncontrolled hypertension
  • Stroke / TIA
  • Hemiplegic / basilar migraine
  • Concurrent or recent MAOI/ergotamine
  • Severe hepatic impairment
  • Concurrent strong CYP3A4 inhibitors (avoid)

Side effects

  • Tightness/pressure (chest, throat)
  • Dizziness
  • Drowsiness
  • Tingling
  • Medication overuse headache

Interactions

  • MAOIs
  • Ergotamine (separate by 24h)
  • Strong CYP3A4 inhibitors (avoid: clarithromycin, ritonavir, ketoconazole)
  • Other serotonergics

Monitoring

  • Headache diary
  • CV risk factors
  • MOH risk

Reference: BNF; NICE NG150; BASH; ABN migraine guidance; https://bnf.nice.org.uk/drugs/eletriptan/. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.